医用多肽

Search documents
康鹏科技: 关于使用部分闲置募集资金进行现金管理的公告
Zheng Quan Zhi Xing· 2025-08-18 16:17
Core Viewpoint - The company plans to utilize part of its idle raised funds, not exceeding RMB 650 million, for cash management to enhance fund efficiency while ensuring the safety and proper use of the raised funds [1][4][6]. Fundraising Overview - The company raised a total of RMB 838.59 million from its initial public offering, with a net amount of RMB 810.66 million after deducting issuance costs [1][2]. - The funds are managed in a dedicated account, adhering to regulatory requirements [1][2]. Fund Utilization Plan - The net amount from the fundraising is RMB 810.66 million, with specific projects planned for investment [2][3]. - The company acknowledges that some of the raised funds may temporarily remain idle due to project timelines [3]. Cash Management Plan - The company intends to invest the idle funds in high-security, liquid, and capital-protected financial products, including but not limited to time deposits and structured deposits [4][6]. - The cash management period will not exceed 12 months from the board's approval date, allowing for rolling use of the funds within the specified limit [3][4]. Impact on Daily Operations - The cash management plan will not affect the company's normal operational cash flow or the execution of investment projects [4][6]. - The strategy aims to generate additional returns on idle funds, benefiting overall company performance and shareholder returns [4][6]. Approval Process - The board of directors approved the cash management proposal on August 15, 2025, without requiring shareholder meeting approval [6][7]. - The proposal complies with relevant regulations and internal management policies [6][7].